Invion Limited

Clinical stage company developing the next-gen Photodynamic Therapy (PDT), called Photosoft, for the treatment of a range of cancers & infectious diseases

[Invion Limited @InvionLimited]

We are excited to be profiled by Stockhead in The Australian with the publication showcasing our promising Photosoft technology in fighting cancers. Click here to read more https://t.co/IGhZXQC2BM #stockstofocus #ASX #Biotechnology #investing #Oncology #CancerResearch

[Brendon Lau @brenlau]

Solid safety data from @InvionLimited's Ph2 prostate cancer trial very encouraging vs potential side effects from radiotherapy/surgery (urinary incontinence, bowel & erectile dysfunction, infertility) https://t.co/DvaxoMn5Qm #CancerResearch #Oncology #smallcap #StocksInFocus

[Invion Limited @InvionLimited]

Following our positive Phase 2 Prostate Cancer Trial results, many have asked how Photosoft works. This 1 minute animation explains the mechanism of action #CancerResearch #ASX #biotech #StocksInFocus #Stocks #stockinvesting #SmallCaps

[Small Caps @SmallCapsASX]

Invion’s (#ASX: $IVX) INV043 candidate demonstrates positive results in Phase II prostate cancer trial.
https://t.co/7yhpJ6KJlK @InvionLimited

[Invion Limited @InvionLimited]

Webinar where Invion's CEO, Thian Chew, spoke about the successful Ph 2 prostate cancer results, the Ph 1/2 skin cancer trial and what these mean for Invion in the near-term. https://t.co/89MmBRSBs9

#investing #investments #cancerresearch #ASX #stockstowatch #smallcaps #biotech

[Invion Limited @InvionLimited]

Results from Ph 2 prostate cancer trial using INV043 showed it to be safe & well tolerated by patients, 40% showed a positive response using RECIST 1.1 (10% complete regression) & 44% negative on PSMA-PET. https://t.co/4ix8XZBFsW #asx #smallcaps #CancerResearch #investing

[Invion Limited @InvionLimited]

Invion eyes multiple applications and new markets for next-generation photodynamic therapy #investments #ASX #biotech #Covid_19 #shares #stocks
https://t.co/LLGeL1r3pa

[Invion Limited @InvionLimited]

Invion's (ASX: IVX) CEO Thian Chew speaks with 180 Markets about what makes Invion's next-gen PDT technology so unique as a potential cancer treatment @180Markets #markets #health #healthtech #cancer #asxnews #biotech https://t.co/BHgqfP0UVF

[Invion Limited @InvionLimited]

.@InvionLimited & the Hudson Institute, have announced significant in vitro data for the new IVXP02 PhotosoftTM formulation, including a validated at 15x potency compared to other PDT treatments for ovarian cancer cells. See more here - https://t.co/G81KJPvaU3 #IVX #ASX #ausbio

[Invion Limited @InvionLimited]

Asthma cases declining in U.S., survey suggests http://t.co/essIv3A6wX via @CTVNews

[BoardroomMedia @boardroom_media]

.@InvionLimited experts provide development update on company's chronic inflammation treatment [Video] http://t.co/I3dKb6NgzR #ausbiz #asx

[Invion Limited @InvionLimited]

Despite debilitating disease, American woman calls herself lupus thriver http://t.co/HvwSXQBJ8Y

[Invion Limited @InvionLimited]

Researchers offer healthy foods chart for asthma sufferers http://t.co/os1H4qaABg via @ABCNews

[Invion Limited @InvionLimited]

Alert over alternative treatment for childhood asthma http://t.co/r3FvaL0w0A via @abcnews

[Invion Limited @InvionLimited]

Study Aims to Curb #Asthma Over-Medication http://t.co/y66dLAFI5i via @NBCLA

[Invion Limited @InvionLimited]

Smoking cessation: It's good for mental health too http://t.co/PR04kYaVQv @RachaelRettner via @livescience

[Invion Limited @InvionLimited]

@IndiacomHealth publishes 8 facts you ought to know about #lupus. Read more http://t.co/vDrStEkUJn

[Invion Limited @InvionLimited]

“Smokers don’t need lectures or sermons, they need medical assistance,” @picardonhealth http://t.co/nl3jrpamqg

[Invion Limited @InvionLimited]

Study suggests green tea reduces the effect of blood pressure medicine, Nadolol http://t.co/XPoSoy2sFK

[Invion Limited @InvionLimited]

Scientists developed a new drug that could treat #asthma and #COPD simultaneously http://t.co/Ma6dXkhP7X